GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (LSE:VRCI) » Definitions » Gross Profit

Verici Dx (LSE:VRCI) Gross Profit : £0.01 Mil (TTM As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Verici Dx Gross Profit?

Verici Dx's gross profit for the six months ended in Jun. 2023 was £0.01 Mil. Verici Dx's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was £0.01 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Verici Dx's gross profit for the six months ended in Jun. 2023 was £0.01 Mil. Verici Dx's Revenue for the six months ended in Jun. 2023 was £0.02 Mil. Therefore, Verici Dx's Gross Margin % for the quarter that ended in Jun. 2023 was 86.67%.

Verici Dx had a gross margin of 86.67% for the quarter that ended in Jun. 2023 => Durable competitive advantage

During the past 3 years, the highest Gross Margin % of Verici Dx was 86.67%. The lowest was 0.00%. And the median was 0.00%.


Verici Dx Gross Profit Historical Data

The historical data trend for Verici Dx's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Gross Profit Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22
Gross Profit
- - -

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23
Gross Profit - - - - 0.01

Competitive Comparison of Verici Dx's Gross Profit

For the Diagnostics & Research subindustry, Verici Dx's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verici Dx's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Gross Profit distribution charts can be found below:

* The bar in red indicates where Verici Dx's Gross Profit falls into.



Verici Dx Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Verici Dx's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Verici Dx's Gross Profit for the quarter that ended in Jun. 2023 is calculated as

Gross Profit (Q: Jun. 2023 )=Revenue - Cost of Goods Sold
=0.015 - 0.002
=0.01

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.01 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Verici Dx's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.01 / 0.015
=86.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Verici Dx  (LSE:VRCI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Verici Dx had a gross margin of 86.67% for the quarter that ended in Jun. 2023 => Durable competitive advantage


Verici Dx Gross Profit Related Terms

Thank you for viewing the detailed overview of Verici Dx's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Verici Dx (LSE:VRCI) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, that of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx (LSE:VRCI) Headlines

No Headlines